Background Several noninvasive tools are available for the assessment of nonalcoholic fatty
liver disease (NAFLD) including clinical and blood biomarkers, transient elastography (TE) …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in
western countries, affecting 25–30% of the general population and up to 65% in those with …

Metabolic dysfunction–associated steatotic liver disease (MASLD), a replacement of the
nomenclature employed for NAFLD, is the most prevalent chronic liver disease worldwide …

Non-alcoholic fatty liver disease (NAFLD), and its progressive form, non-alcoholic
steatohepatitis (NASH), represent, nowadays, real challenges for the healthcare system …

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among
reproductive-age women. Patients with non-alcoholic fatty liver disease (NAFLD) often suffer …

Background Although a few studies have confirmed the association of accelerometer‐
measured sedentary behaviour (SB) and physical activity (PA) with non‐alcoholic fatty liver …

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver diseases and can
progress to advanced fibrosis and end-stage liver disease. Thus, intensive research has …

The number of individuals suffering from fatty liver is increasing worldwide, leading to
interest in the noninvasive study of liver fat. Magnetic resonance spectroscopy (MRS) is a …

Aim To examine the association between 1‐hour plasma glucose (PG) concentration and
markers of non‐alcoholic fatty liver disease (NAFLD) assessed by transient elastography …

Simple Summary Non-alcoholic fatty liver disease (NAFLD) has become a significant public
health concern, affecting over 30% of the population. The incidence of NAFLD-related …